ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines

Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma

Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report

The fate of drug discovery in academia; dumping in the publication landfill?

Retraction: Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice

Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation

BCAS1 defines a heterogeneous cell population in diffuse gliomas

Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma

Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples

Retraction: Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX

Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells

Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland

Combining causal and correlative approaches to discover biomarkers of response to paclitaxel

Retraction: Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells

Correction: Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer

Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas

Correction: Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma

Analytical validation of NeXT Personal^®, an ultra-sensitive personalized circulating tumor DNA assay

Retraction: PDIA6 promotes the proliferation of HeLa cells through activating the Wnt/β-catenin signaling pathway

ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells

From osimertinib to preemptive combinations

Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II–III breast cancer

Retraction: Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e

Novel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface

Correction: Gap junction-mediated transfer of miR-145-5p from microvascular endothelial cells to colon cancer cells inhibits angiogenesis

Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN

Retraction: Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish

Cyclin D1 expression in penile cancer

Retraction: Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer

The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response

Correction: Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1

GZ17-6.02 kills PDX isolates of uveal melanoma

The importance of integrated therapies on cancer: Silibinin, an old and new molecule

Retraction: Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma

Bruton’s tyrosine kinase inhibitor-related cardiotoxicity: The quest for predictive biomarkers and improved risk stratification

Retraction: Long non-coding RNA H19 induces hippocampal neuronal apoptosis via Wnt signaling in a streptozotocin-induced rat model of diabetes mellitus

Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy

When does a melanoma metastasize? Implications for management

Correction: FOXC1 promotes melanoma by activating MST1R/PI3K/AKT pathway and is associated with poor prognosis in melanoma

Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management

Leveraging gold nanostars for precision laser interstitial thermal therapy

Starving cancer cells to enhance DNA damage and immunotherapy response

Genomics has more to reveal

Retraction: Hypoxia-inducible factor 1a induces phenotype switch of human aortic vascular smooth muscle cell through PI3K/AKT/AEG-1 signaling

Targeting ABC transporters in PDAC – past, present, or future?

Correction: Analytical validation of NeXT Personal^®, an ultra-sensitive personalized circulating tumor DNA assay

Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status

Correction: BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV

DDX41 and its unique contribution to myeloid leukemogenesis

Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma

Genotype matters: Personalized screening recommendations for germline CHEK2 variants

Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models

The advances in targeting CD47/SIRPα “do not eat me” axis and their ongoing challenges as an anticancer therapy

Correction: Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics

INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death

Targeting the multifaceted BRAF in cancer: New directions

Rapid but nondurable response of a BRAF exon 15 double-mutated spindle cell sarcoma to a combination of BRAF and MEK inhibitors

Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity

Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma

Beyond pixels: Graph filtration learning unveils new dimensions in hepatocellular carcinoma imaging

Targeting WNT5B and WNT10B in osteosarcoma

Retraction: Berberine and cinnamaldehyde together prevent lung carcinogenesis

Next-generation vaccines are showing promise against glioblastoma

Retraction: IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma

Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival

The gut barrier as a gatekeeper in colorectal cancer treatment

Retraction: The crucial role of SRPK1 in IGF-1-induced EMT of human gastric cancer

A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice

Artificial intelligence: A transformative tool in precision oncology

Retraction: MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1

Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties

Generative AI in oncological imaging: Revolutionizing cancer detection and diagnosis

Trained and ready - the case for an inflammatory memory for hematopoietic stem and progenitor cells in the AML niche

Integrated stress response (ISR) activation and apoptosis through HRI kinase by PG3 and other p53 pathway-restoring cancer therapeutics

Retraction: Myeloid ecotropic viral integration site 1 inhibits cell proliferation, invasion or migration in human gastric cancer

The emerging role of AI in enhancing intratumoral immunotherapy care

Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors

UBA1 dysfunction in VEXAS and cancer

Retraction: Association study of inflammatory cytokine and chemokine expression in hand foot and mouth disease

Lessons from the ACDC-RP trial: Clinical trial design for radical prostatectomy neoadjuvant therapy trials

Zika virus and brain cancer: Can Zika be an effective treatment for brain cancer? A systematic review

Transplant or no transplant for TP53 mutated AML

Correction: Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer

Molecular chaperones: Guardians of tumor suppressor stability and function

Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin

Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition

Gene regulatory network and signalling pathway rewiring: How blood cancer cells shift their shapes to evade drug treatment

Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor

Retraction: Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma

Initiation of tumor dormancy by the lymphovascular embolus

A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy

Correction: The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation

Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC

Beyond the hype: Navigating bias in AI-driven cancer detection

Retraction: MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4

Understanding the interplay between extracellular matrix topology and tumor-immune interactions: Challenges and opportunities

Mitigating bias in radiology: The promise of topological data analysis and simplicial complexes

Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists

Retraction: Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells

B7-H4: A potential therapeutic target in adenoid cystic carcinoma

Computed tomography-based radiomics and body composition model for predicting hepatic decompensation

Retraction: MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway

Advancements in cell-penetrating monoclonal antibody treatment

Pitfalls and perils from FDA-approved germ-line cancer predisposition tests

Retraction: miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1